KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Notes Payables (2016)

Biolife Solutions (BLFS) has disclosed Notes Payables for 1 consecutive years, with $2.8 million as the latest value for Q4 2016.

Quarterly Notes Payables changed N/A to $2.8 million in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2016, changed N/A year-over-year, with the annual reading at $2.8 million for FY2016, N/A changed from the prior year.
Notes Payables for Q4 2016 was $2.8 million at Biolife Solutions, up from $1.8 million in the prior quarter.
The five-year high for Notes Payables was $2.8 million in Q4 2016, with the low at $656809.0 in Q2 2016.